Vascular Perfusion Solutions, Inc. is an early-stage company, formed for the purpose of commercializing accessible, and innovative oxygenated perfusion devices.
We are honored for the opportunity to participate in the Harrison Symposium 2024 at University of California, dedicated to showcasing pediatric innovations.
CEO, Rafael Veraza,received the esteemed Silver Award for presenting the VP.S ENCORE® PEDS technology
#pediatric#vps
Our CEO, @RafaJVeraza, PhD, MPH, is in San Francisco this week for JPM23!
We are thrilled for the collaborations and connections that will flourish from the largest healthcare investment symposium in the industry! #JPM23#heartpreservation#perfusion
We are thrilled to announce that Cristiano Amarelli, MD, Distinguished Cardiac Surgeon, has joined the VPS Scientific & Clinical Advisory Board.
Dr. Amarelli has over 15 years of experience in the field of transplantation, mechanical valve and mechanical circulatory support.
Today we celebrate our 100th heart experiment! We are so grateful for our dedicated team working effortlessly to advance the V.P.S. ENCORE.
Thank you to everyone who has supported us and contributed during this journey
Happy thanksgiving from our families to yours. We are grateful for our wonderful VPS team for tirelessly working to progress the life saving technologies for the future. We wish everyone safe travels and joyful times with friends and family. #HappyThanksgiving2022
At VPS, we are very fortunate to collaborate with these amazing organizations to advance our mission of Saving Organs, Saving Lives. Shoutout to The Health Cell- SA for arranging this event to increase awareness in the field of transplantation.
CEO & President, Rafael Veraza, PhD, MPH, moderated a conversation between leading professionals in the transplant field, Jennifer Milton, Jessica Rudd, Jim Wagner, & Chris Bronaugh, who shared the story of the collaboration for the Center For Life in SATX
So proud of our team! And excited about this next phase as we prepare new medicines to actually improve patient lives.
Nuts to be featured in the @FinancialTimes. I used to stack the FT every Sunday morning at work growing up in Ireland.
https://t.co/vWsGJLgOL8
We join #Worldheartday with our commitment to continue working in developing simple and accessible medical devices to preserve hearts for transplantation.
#worldheartday#withheart#medtech
Pleased to announce that @RafaJVeraza has been named Chief Executive Officer for VPS. Dr. Veraza brings more than 15 years of research experience, having served most recently as Chief Technology and Scientific Officer for VPS.